Liniment Pharma Private Limited, a active private limited company, was established on 26 February 2018 in Jaipur, Rajasthan, India. Engaging in drug formulation & development within the transport and storage sector, it holds CIN: U24304RJ2018PTC060344. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.24 M.
Employing 10 professional, Its leadership includes Rohit Bafna (Director), Aastha Dusad (Director). Past directors included Shakti Singh Rao, Jaydeep Dosi, Rahul Gautam. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.-38,Shankar Colony Naya Kheda, Ambabari, Jaipur, Rajasthan, 302039.
U24304RJ2018PTC060344
060344
26 February 2018
₹1.00 M
₹0.24 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Liniment Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Bafna | Director | 26 Feb 2018 | Current |
| Aastha Dusad | Director | 26 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 May 2018 | Past |
| Pramod Abcsdd | Director | 25 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 13 Feb 2020 | Past |
| Pramod Abcsdd | Additional Director | 15 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Liniment Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 79.16% increase. The company also saw a substantial fall in profitability, with a 45.19% decrease in profit. The company's net worth Soared by an impressive increase of 593.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Liniment Pharma had a promoter holding of 73.97% and a public holding of 26.03%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Liniment Pharma has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Liniment Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Liniment Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Liniment Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Liniment Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was completed.
Progress on Rohit Bafna was appointed as a Director was appointed as a Director on 26 Feb 2018 & has been associated with this company since 7 years 9 months . was documented.
The activity Aastha Dusad was appointed as a Director was appointed as a Director on 26 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
The activity Liniment Pharma Private Limited was registered on 26 Feb 2018 with Roc Jaipur & aged 7 years 9 months as per MCA records. was completed.
The CIN of Liniment Pharma Private Limited is U24304RJ2018PTC060344.
Liniment Pharma Private Limited is headquartered at Plot No.-38,Shankar Colony Naya Kheda, Ambabari, Jaipur, Rajasthan, 302039.
Liniment Pharma Private Limited was incorporated on 26 February 2018.
The current directors of Liniment Pharma Private Limited are
The primary industry of Liniment Pharma Private Limited is Transport And Storage.
Liniment Pharma Private Limited is unlisted.
The authorized capital of Liniment Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.24 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX